Dr. Partha Karmakar is Doctor of Philosophy in Chemistry, University of Toledo, Toledo, Ohio, USA. Currently he is a Post-Doctoral Research Associate, Washington University School of Medicine, St. Louis, MO, USA. Dr. Karmakar\'s research at the Washington University School of Medicine involves the development of new therapeutic strategy for cancer treatment that involves development of small molecules, bioconjugates and nanoparticle-based photosensitizer and radionuclide probes, in-vitro and in-vivo efficacy study and moving towards clinical translation. Prior to this, he worked at GlaxoSmithKline – Pennsylvania-Antibacterial drug discovery, on the development and optimization of a lead molecule targeting bacterial colony growth mechanism. Dr. Karmakar\'s PhD research involves development of glycopeptide-based vaccines and their in-vivo immunological evaluation.